For many modern women, the concept of fertility is something to consider later, when life feels steady and the timing feels right. Now more than ever, trends that encourage delaying partnership, questioning traditional paths, or seeking information earlier are...
A Neurodevelopmental Framework for Strategic Life Construction In an era defined by rapid technological change, algorithmic persuasion, and rising rates of youth anxiety, the question is no longer whether children need education, but what kind of education is most...
70,000 sq. ft. facility expands the company's biopharma, chemical and cold chain storage capacities DUBLIN, Ireland, (March 6, 2026) - Thermo Fisher Scientific Inc, the world leader in serving science, today announced the opening of a new, 70,000 sq.ft. distribution...
People living with dementia will help close a long-standing weakness in research - the clinical trial evidence gap - in a new home-based study. While those over 65 account for two-thirds of illness in the UK, they make up just one-third of trial participants. This...
In its most significant structural overhaul since the 2021 Organon spin-off, MSD (known as Merck & Co. in the U.S. and Canada) has announced the division of its Human Health business into two standalone units: an Oncology Business Unit and a Specialty, Pharma...
A New Era for EHR Data A new study published in the latest issue of the Royal College of Physicians’ Future Healthcare Journal introduces PICTURE, an innovative data platform designed to convert routine electronic health record (EHR) data into actionable clinical...
Thousands of people living with schizophrenia and severe depression are being recruited by the NHS for a major new study which could unlock a “new era” of personalised treatment for severe mental illness. As part of the world’s largest mental health study, researchers...
THX Pharma (formerly known as Theranexus) has entered into a strategic licensing agreement with French pharmaceutical company Biocodex covering two experimental programs, Batten-1 and TX01, in a move aimed at accelerating development and expanding commercial reach....
Auxilium and Massachusetts Biomedical Initiatives (MBI) have announced a joint life sciences accelerator cohort in Worcester designed to attract and support founders developing the next generation of healthcare and life sciences technologies. Founders selected for the...
Cholesterol-lowering drugs known as statins, taken by millions worldwide, are significantly safer than often perceived, according to a major new scientific analysis. Conducted by the Cholesterol Treatment Trialists’ (CTT) Collaboration and published in The Lancet, the...
Eli Lilly and Company has officially selected Fogelsville, Pennsylvania, as the site for its newest $3.5 billion injectable medicine and device manufacturing facility. Operating under the name "Lilly Lehigh Valley," the project represents the final piece of a quartet...
AstraZeneca has announced plans to invest up to 15 billion US dollars to expand its research, development, and manufacturing operations in China, reinforcing the country’s role as a central pillar of the company’s global strategy. The long-term investment will fund...
Phacilitate announces the return of Advanced Therapies Week (ATW) for its 22nd year, reinforcing its status as one of the most established and influential cell and gene therapy (CGT) conferences in the United States and among the most recognized globally. In...
New research published (22 January 2026) in The Lancet Psychiatry warn that lessons have not been learned from the pandemic when it comes to mental health. The researchers recommend that mental health should be treated as a core consideration when it comes to pandemic...
Thousands of men in England with advanced prostate cancer are set to gain access to a new life extending treatment following a decision by the National Institute for Health and Care Excellence. The move marks a significant development in the management of one of the...
Oxford Biomedica has officially confirmed it is in preliminary discussions with the Swedish private equity giant EQT regarding a potential cash takeover. The announcement follows significant market speculation and a sharp rise in the company’s share price on January...
In a move that signals a significant shift in the global pharmaceutical supply chain landscape, Thermo Fisher Scientific (NYSE: TMO) has announced a substantial influx of new contracts within its pharmaceutical services business. The common thread among these new...
Press Release: Patients to benefit sooner as UK boosts clinical trials attractiveness with faster assessments and agile regulation The MHRA is now setting out the next phase of reforms for 2026, aimed at helping patients access new cutting-edge treatments more...